Memoral Sloan Kettering Monmouth

Middletown, New Jersey 07748

1 studies enrolling now · 10 studies all time

What they study most

Cutaneous Squamous Cell Carcinoma, Endometrial Cancer, Head and Neck Cancer, Head and Neck Carcinoma, Head and Neck Squamous Cell Carcinoma, Lymphoma, Lymphoplasmacytic Lymphoma, Metastatic Anaplastic Thyroid Cancer, Metastatic Melanoma, Multiple Myeloma, Nasal Cavity Adenocarcinoma, Nasal Cavity Tumor

Studies at this site

• A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) — Recruiting now
• Short Course Daratumumab in Patients With Multiple Myeloma — Completed
• A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages — Completed
• Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma — Completed
• Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer — Completed
• Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers — Completed
• A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery — Completed
• Study of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular Lymphoma — Stopped early
• Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors — Completed
• A Study of Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of Solitary Bone Plasmacytoma — Withdrawn before enrolling